The order is significant as the high-profile murder trial, pending since 2015, is in its final stages after the examination ...

This week's Optimizer delves into the gaming community's reaction to biohacker Bryan Johnson revealing his diagnosis of autoimmune gastritis.

Bryan Johnson, a 48-year-old biotech entrepreneur determined to live "multiple lifetimes" with his teenage son, shared the ...

USP’s Diane McCarthy on the emerging standards platform and opportunities for stakeholders to help shape standards evolution.

That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...

The documentary gives fans an inside look at the controversial Enhanced Games, and what happens when athletes are permitted ...

EXCLUSIVE: Sundance Institute has announced the creative teams taking part in the 2026 edition of its Documentary Edit Intensive, taking place at Francis Ford Coppola's All-Movie Hotel in Peachtree ...

Two federal lawmakers have introduced a bill seeking to apply the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act to investments in Chinese biotechnology.

Filmmaker Daniel Roher investigates the positives and negatives of the artificial intelligence boom and what it means for the future of humanity in The AI Doc: Or How I Became an Apocaloptimist.

Netflix is a haven for documentaries, but let’s face it, there are so many to. choose from that sometimes it’s hard to decide which ones are worth your time. Well, you’re in luck. We’ve seen a lot of ...

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...